BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1520354
Paris, I0
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$446,010,389
+$67,323,483 QoQ
Shares Held
897,893
+5.9% QoQ
Ownership
0.354%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#38
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,207,592 across 136 Biotechnology names. VRTX ranks #1 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
897,893 | $446,010,389 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
331,560 | $206,740,921 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
799,297 | $192,606,596 | |
| 4 | ARGX |
Argenx SE
|
121,786 | $112,989,396 | |
| 5 | INCY |
Incyte Corp
|
937,763 | $106,304,813 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,290,731 | $77,908,522 | |
| 7 | VCEL |
Vericel Corp
|
1,639,988 | $72,963,065 | |
| 8 | CYTK |
Cytokinetics Inc
|
827,810 | $70,521,132 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $446,010,389 | 897,893 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $378,686,906 | 848,047 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $303,663,699 | 669,807 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $178,718,254 | 456,333 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $197,873,146 | 444,459 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $190,055,741 | 392,013 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $156,914,872 | 389,657 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $184,180,515 | 396,019 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $191,054,958 | 407,610 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $203,518,617 | 486,875 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $244,750,030 | 601,514 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $239,992,064 | 690,148 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $224,089,952 | 636,782 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $242,486,378 | 769,627 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $194,298,979 | 672,827 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $116,367,862 | 401,906 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $145,718,963 | 517,119 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $131,942,256 | 505,584 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $54,104,828 | 246,379 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $37,047,456 | 204,242 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $59,683,890 | 296,007 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $73,247,618 | 340,861 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $94,956,211 | 401,778 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $128,265,665 | 471,357 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $122,610,685 | 422,344 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $91,155,550 | 383,087 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||